Skip to main content

Cancer Biomarkers

Promotes research to identify, develop, and validate biological markers for early cancer detection, risk prediction, and prevention. Supports development of collaborative databases and informatics systems, advancement of new technologies, and refinement of existing technologies.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	Evans Williams, Felicia, M.B.A. felicia.evanslong@nih.gov 240-276-5076	5E636	Program Analyst \| Cancer Biomarkers
	Fu, Sidney, M.D. sidney.fu@nih.gov 240-276-6669	5E134	Program Officer \| Cancer Biomarkers
	Hodges, Nicholas, Ph.D. nick.hodges@nih.gov 240-276-7844	5E616	Program Officer \| Cancer Biomarkers
	Kohaar, Indu, Ph.D., M.Phil., M.Sc. indu.kohaar@nih.gov 240-620-0875	5E612	Program Officer \| Cancer Biomarkers
	Krueger, Karl, Ph.D. [V] karl.krueger@nih.gov		Volunteer \| Cancer Biomarkers
	Marquez, Guillermo, Ph.D. guillermo.marquez@nih.gov 240-276-7035	5E132	Program Officer \| Cancer Biomarkers
	Orr, Susan susan.orr@nih.gov 240-276-5001	5E626	Program Support Assistant \| Cancer Biomarkers
	Patriotis, Christos, Ph.D., M.Sc. christos.patriotis@nih.gov 240-276-7134	5E614	Deputy Chief \| Cancer Biomarkers
	Petruzzelli, Angie angie.petruzzelli@nih.gov 240-276-5076	5E624	Program Support Assistant \| Cancer Biomarkers
	Srivastava, Sudhir, Ph.D., M.P.H. sudhir.srivastava@nih.gov 240-276-7028	5E136	Chief \| Cancer Biomarkers
	Villanueva, Juan Miguel juan.villanueva@nih.gov	5E630	Program Analyst \| Cancer Biomarkers
	Wang, Wendy, Ph.D., M.Sc. wendy.wang@nih.gov 240-276-7117	5E566	Program Officer \| Cancer Biomarkers
	Young, Matthew, Ph.D. matthew.young@nih.gov 240-276-5846	5E610	Program Officer \| Cancer Biomarkers

Grants

PI Name	PI Organization Sort descending	Title	Grant Number	Program Official
Lubman, David M.	University Of Michigan At Ann Arbor United States	Serum Glyco-Markers of Early Hepatocellular Carcinoma Using a Mass Spec Approach	5R01CA160254-14	Matthew Young, Ph.D.
Brand, Randall	University Of Pittsburgh At Pittsburgh United States	Validation of biomarkers for risk prediction and early diagnosis of Pancreatic Adenocarcinoma	5U01CA200466-08	Matthew Young, Ph.D.
Castro, Cesar M	Massachusetts General Hospital United States	Composing CODAs to cervical cancer screening through an integrated CRISPR and fluorescent nucleic acid approach	3U01CA279858-03S2	Christos Patriotis, Ph.D., M.Sc.
Grogan, Eric L	Vanderbilt University Medical Center United States	Clinical Utility of a Combined Biomarker Approach to Diagnose Lung Cancer	4U01CA152662-14	Guillermo Marquez, Ph.D.
Wei, Lei	Roswell Park Cancer Institute Corp United States	Advancing skin cancer prevention by tackling UV-induced clonogenic mutations	5R01CA255242-05	Wendy Wang, Ph.D., M.Sc.
Anderson, Karen Sue	Arizona State University-Tempe Campus United States	Southwest EDRN Clinical Validation Center for Head and Neck Cancer	5U01CA281660-03	Wendy Wang, Ph.D., M.Sc.
Badve, Sunil S.	Emory University United States	Early prediction of lethal phenotypes in triple negative breast cancer using multiscale, multi-modality platforms	5R01CA281932-02	Wendy Wang, Ph.D., M.Sc.
Zhu, Yazhen	University Of California Los Angeles United States	Extracellular Vesicle-Based Digital Scoring Assay for Detecting Early-stage Hepatocellular Carcinoma	5R01CA255727-05	Matthew Young, Ph.D.
Wolpin, Brian Matthew	Dana-Farber Cancer Inst United States	Altered metabolism and machine learning for pancreatic cancer early detection	5U01CA210171-09	Matthew Young, Ph.D.
Ahn, Eun Hyun	Johns Hopkins University United States	Engineered biomimetic collective cancer invasion models for screening chemotherapeutic agents	5R01CA279948-02	Guillermo Marquez, Ph.D.
Oberg, Ann Laura	Mayo Clinic Rochester United States	Management and Data Coordination Unit for PCDC	5U24CA274496-04	Guillermo Marquez, Ph.D.
Slager, Susan L	Mayo Clinic Rochester United States	The genetic and epigenetic etiology of progression from the precursor state to chronic lymphocytic leukemia (CLL)	4R01CA258465-04	Nicholas Hodges, Ph.D.
Martinez-Conde, Susana	Suny Downstate Medical Center United States	Novel Perceptual and Oculomotor Heuristics for Enhancing Radiologic Performance	5R01CA258021-05	Guillermo Marquez, Ph.D.
Nappi, Lucia	Provincial Health Services Authority United States	Integrating investigational miR371a-3p with conventional radiology imaging for earlier and more precise detection of active germ cell malignancy: A BCC/SWOG/S1823 secondary use of data collaboration.	5R37CA264798-03	Guillermo Marquez, Ph.D.
Shah, Sohrab P	Sloan-Kettering Inst Can Research United States	Exploiting markers of genomic instability in high-risk pre-invasive ovarian cancer	5R01CA281928-03	Christos Patriotis, Ph.D., M.Sc.